EP 3417861 B1 20200923 - PHARMACEUTICAL COMPOSITION CONTAINING JAK KINASE INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Title (en)
PHARMACEUTICAL COMPOSITION CONTAINING JAK KINASE INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT JAK-KINASEINHIBITOR ODER PHARMAZEUTISCH UNBEDENKLICHEM SALZ DAVON
Title (fr)
COMPOSITION PHARMACEUTIQUE CONTENANT UN INHIBITEUR DE JANUS KINASE (JAK) OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI
Publication
Application
Priority
- CN 201610094168 A 20160219
- CN 2017073869 W 20170217
Abstract (en)
[origin: EP3417861A1] Provided in the present invention is a pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof. In particular, provided in the present invention is a pharmaceutical composition containing (3aR, 5s, 6aS)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl(7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino) hexahydrocyclopenta [c] pyrrol-2 (1H)-carboxamide, or a pharmaceutically acceptable salt thereof, and cellulose ether. The pharmaceutical composition of the present invention is characterized by rapid dissolution rate and good stability.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/519 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP KR RU US)
A61K 9/2018 (2013.01 - EP US); A61K 9/2054 (2013.01 - KR US); A61K 31/519 (2013.01 - EP KR RU US); A61K 47/38 (2013.01 - RU); A61P 19/02 (2017.12 - EP RU); A61P 29/00 (2017.12 - EP KR); A61P 43/00 (2017.12 - EP); A61K 9/2027 (2013.01 - EP US); A61K 9/2059 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3417861 A1 20181226; EP 3417861 A4 20190918; EP 3417861 B1 20200923; AU 2017220971 A1 20180802; BR 112018015369 A2 20181218; CA 3014090 A1 20170824; CN 107530348 A 20180102; CN 107530348 B 20201020; HK 1244704 A1 20180817; JP 2019505525 A 20190228; JP 6875407 B2 20210526; KR 20180109992 A 20181008; MX 2018009741 A 20181109; RU 2018129775 A 20200319; RU 2018129775 A3 20200525; RU 2744432 C2 20210309; TW 201729812 A 20170901; TW I745349 B 20211111; US 10786507 B2 20200929; US 2019030033 A1 20190131; WO 2017140254 A1 20170824
DOCDB simple family (application)
EP 17752686 A 20170217; AU 2017220971 A 20170217; BR 112018015369 A 20170217; CA 3014090 A 20170217; CN 2017073869 W 20170217; CN 201780001376 A 20170217; HK 18104329 A 20180329; JP 2018537438 A 20170217; KR 20187025163 A 20170217; MX 2018009741 A 20170217; RU 2018129775 A 20170217; TW 106105457 A 20170218; US 201716077135 A 20170217